Literature DB >> 15236051

Effects of sevoflurane on myocardial metabolism during postischemic reperfusion in the rat.

S Kashimoto1, T Oguchi, M Kume, M Manabe, T Kumazawa.   

Abstract

In experiments on isolated rat heart lung preparation, the effects of sevoflurane on myocardial metabolism during postischemic reperfusion were evaluated with intramyocardial high energy phosphates, lactate and glycogen. Hearts were perfused for 10 min initially and made globally ischemic for 8 min. Afterwards, they were reperfused for 12 min. Sevoflurane was administered from 5 min after the start of perfusion to the end of reperfusion. There was no significant difference in myocardial lactate levels between the sevoflurane (S) and control groups. However, the myocardial ATP level in Group S was significantly higher than that in control (17.45 +/- 1.51 vs 15.50 +/- 0.87 : P < 0.01). The administration of sevoflurane to the isolated rat heart during pre- and post-ischemia enhanced metabolic recovery in the postischemic state.

Entities:  

Year:  1989        PMID: 15236051     DOI: 10.1007/s0054090030023

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  11 in total

1.  [New values for the molar extinction coefficients of NADH and NADPH for the use in routine laboratories (author's transl)].

Authors:  H U Bergmeyer
Journal:  Z Klin Chem Klin Biochem       Date:  1975-11

2.  Effects of isoflurane on myocardial metabolism during postischaemic reperfusion in the rat.

Authors:  S Kashimoto
Journal:  Acta Anaesthesiol Scand       Date:  1988-04       Impact factor: 2.105

3.  Sevoflurane: a new inhalational anesthetic agent.

Authors:  R F Wallin; B M Regan; M D Napoli; I J Stern
Journal:  Anesth Analg       Date:  1975 Nov-Dec       Impact factor: 5.108

4.  Effects of halothane and enflurane on myocardial metabolism during postischaemic reperfusion in the rat.

Authors:  S Kashimoto; Y Tsuji; T Kumazawa
Journal:  Acta Anaesthesiol Scand       Date:  1987-01       Impact factor: 2.105

5.  Effects of volatile anesthetics on myocardial oxidation-reduction status assessed by NADH fluorometry.

Authors:  I Kissin; D F Aultman; L R Smith
Journal:  Anesthesiology       Date:  1983-11       Impact factor: 7.892

6.  Regional blood flow during isoflurane and halothane anesthesia.

Authors:  S Gelman; K C Fowler; L R Smith
Journal:  Anesth Analg       Date:  1984-06       Impact factor: 5.108

7.  Porcine systemic and regional organ blood flow during 1.0 and 1.5 minimum alveolar concentrations of sevoflurane anesthesia without and with 50% nitrous oxide.

Authors:  M Manohar; C M Parks
Journal:  J Pharmacol Exp Ther       Date:  1984-12       Impact factor: 4.030

8.  Partition coefficients for sevoflurane in human blood, saline, and olive oil.

Authors:  D P Strum; E I Eger
Journal:  Anesth Analg       Date:  1987-07       Impact factor: 5.108

9.  Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers.

Authors:  D A Holaday; F R Smith
Journal:  Anesthesiology       Date:  1981-02       Impact factor: 7.892

10.  The minimum alveolar concentration (MAC) of sevoflurane in humans.

Authors:  T Katoh; K Ikeda
Journal:  Anesthesiology       Date:  1987-03       Impact factor: 7.892

View more
  2 in total

1.  Effects and interaction of nicardipine and volatile anesthetics in the rat heart-lung preparation.

Authors:  Satoshi Kashimoto; Toshihiro Nakamura; Masaki Kume; Akihiko Nonaka; Teruo Kumazawa
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

2.  Sevoflurane Preconditioning plus Postconditioning Decreases Inflammatory Response with Hemodynamic Recovery in Experimental Liver Ischemia Reperfusion.

Authors:  Estela Regina Ramos Figueira; Joel Avancini Rocha-Filho; Cinthia Lanchotte; Ana Maria Mendonça Coelho; Mauro Nakatani; Eduardo Ryoiti Tatebe; Jonathan Augusto Venceslau Lima; Camilla Oliveira Mendes; Bruno Camargo Rocha Paim de Araujo; Emilio Elias Abdo; Luiz Carneiro D'Albuquerque; Flavio Henrique Ferreira Galvão
Journal:  Gastroenterol Res Pract       Date:  2019-04-07       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.